MKNK1 and melanoma: While we showed that the MNK1/2-eIF4E axis promotes the translation of NGFR, melanoma phenotype switching and therapy resistance (146), little evidence links NGFR inhibition with a fully reversed switch in melanoma cells (13, 79).